Literature DB >> 25448668

Evaluation of digital infra-red thermal imaging as an adjunctive screening method for breast carcinoma: a pilot study.

Muffazzal Rassiwala1, Poonam Mathur2, Rajkumar Mathur3, Khan Farid3, Sapna Shukla3, P K Gupta4, Beena Jain4.   

Abstract

BACKGROUND: Early screening plays a pivotal role in management of breast cancer. Given the socio-economic situation in India, there is a strong felt need for a screening tool which reaches the masses rather than waiting for the masses to reach tertiary centers to be screened. Digital infra-red thermal imaging (DITI) or breast thermography as a screening test offers this possibility and needs to be carefully assessed in Indian scenario.
METHODS: The study involved 1008 female patients of age 20-60 years that had not been diagnosed of cancer of breast earlier. All the subjects in this population were screened for both the breasts using DITI. Based on the measured temperature gradients (ΔT) in thermograms, the subjects were classified in one of the three groups, normal (ΔT ≤ 2.5), abnormal (ΔT > 2.5, <3) and potentially having breast cancer (ΔT ≥ 3). All those having (ΔT > 2.5) underwent triple assessment that consisted of clinical examination, radiological and histopathological examination. Those with normal thermograms were subjected to only clinical examination.
RESULTS: Forty nine female breasts had thermograms with temperature gradients exceeding 2.5 and were subjected to triple assessment. Forty one of these which had ΔT ≥ 3 were proven to be having cancer of breast and were offered suitable treatment. Eight thermograms had temperature gradients exceeding 2.5 but less than 3. Most of these were lactating mothers or had fibrocystic breast diseases. As a screening modality, DITI showed sensitivity of 97.6%, specificity of 99.17%, positive predictive value 83.67% and negative predictive value 99.89%.
CONCLUSION: Based on the results of this study involving 1008 subjects for screening of breast cancer, thermography turns out to be a very useful tool for screening. Because it is non-contact, pain-free, radiation free and comparatively portable it can be used in as a proactive technique for detection of breast carcinoma.
Copyright © 2014 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Breast cancer; Digital infrared thermal imaging (DITI); Mammography; Screening; Thermography

Mesh:

Year:  2014        PMID: 25448668     DOI: 10.1016/j.ijsu.2014.10.010

Source DB:  PubMed          Journal:  Int J Surg        ISSN: 1743-9159            Impact factor:   6.071


  5 in total

1.  Infrared Imaging Tools for Diagnostic Applications in Dermatology.

Authors:  Abhijit Achyut Gurjarpadhye; Mansi Bharat Parekh; Arita Dubnika; Jayakumar Rajadas; Mohammed Inayathullah
Journal:  SM J Clin Med Imaging       Date:  2015-11-20

2.  Accuracy and Reliability of Infrared Thermography in Assessment of the Breasts of Women Affected by Cancer.

Authors:  Rinaldo Roberto de Jesus Guirro; Maíta Marade Oliveira Lima Leite Vaz; Lais Mara Siqueira das Neves; Almir Vieira Dibai-Filho; Hélio Humberto Angotti Carrara; Elaine Caldeira de Oliveira Guirro
Journal:  J Med Syst       Date:  2017-04-12       Impact factor: 4.460

3.  [Diagnostic test for detection of cervical lymph node metastasis from oral squamous cell carcinoma via infrared thermal imaging].

Authors:  C Sb Tao; F Dong; D C Wang; C B Guo
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2019-10-18

4.  Breast Cancer Identification via Thermography Image Segmentation with a Gradient Vector Flow and a Convolutional Neural Network.

Authors:  Santiago Tello-Mijares; Fomuy Woo; Francisco Flores
Journal:  J Healthc Eng       Date:  2019-11-03       Impact factor: 2.682

5.  Observational Study to Evaluate the Clinical Efficacy of Thermalytix for Detecting Breast Cancer in Symptomatic and Asymptomatic Women.

Authors:  Siva Teja Kakileti; Himanshu J Madhu; Lakshmi Krishnan; Geetha Manjunath; Sudhakar Sampangi; H V Ramprakash
Journal:  JCO Glob Oncol       Date:  2020-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.